

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.40330716 |
| 2 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.15865820 |
| 3 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 6.09818670 |
| 4 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.88487985 |
| 5 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82718635 |
| 6 | * negative regulation of cell killing (GO:0031342) | 5.82718635 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53768245 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66760945 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.66760945 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66760945 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66760945 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66760945 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.66760945 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42938530 |
| 15 | * detection of other organism (GO:0098543) | 4.14108248 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.12920284 |
| 17 | leukocyte aggregation (GO:0070486) | 4.12740055 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.12072923 |
| 19 | * cellular response to type I interferon (GO:0071357) | 4.12064070 |
| 20 | * type I interferon signaling pathway (GO:0060337) | 4.12064070 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.11726102 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.10946592 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10395918 |
| 24 | * response to type I interferon (GO:0034340) | 4.09734826 |
| 25 | * detection of bacterium (GO:0016045) | 4.09515725 |
| 26 | response to interleukin-15 (GO:0070672) | 3.92111800 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.87920941 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.85214422 |
| 29 | response to peptidoglycan (GO:0032494) | 3.75509068 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.73740618 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.72529956 |
| 32 | negative T cell selection (GO:0043383) | 3.65924025 |
| 33 | cellular response to interleukin-15 (GO:0071350) | 3.64738609 |
| 34 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62132124 |
| 35 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.60240699 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.59088253 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57649573 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52266113 |
| 39 | regulation of tolerance induction (GO:0002643) | 3.51657103 |
| 40 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.49622810 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.47062098 |
| 42 | * detection of external biotic stimulus (GO:0098581) | 3.41247278 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40143789 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.38709635 |
| 45 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.38480335 |
| 46 | cellular extravasation (GO:0045123) | 3.35054468 |
| 47 | tolerance induction (GO:0002507) | 3.34827130 |
| 48 | respiratory burst (GO:0045730) | 3.33682498 |
| 49 | B cell receptor signaling pathway (GO:0050853) | 3.32398267 |
| 50 | germinal center formation (GO:0002467) | 3.31092902 |
| 51 | T cell migration (GO:0072678) | 3.30292307 |
| 52 | B cell mediated immunity (GO:0019724) | 3.20410978 |
| 53 | thymic T cell selection (GO:0045061) | 3.19571945 |
| 54 | neutrophil activation (GO:0042119) | 3.18727504 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.18431177 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17613943 |
| 57 | response to host immune response (GO:0052572) | 3.17613943 |
| 58 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15330712 |
| 59 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14524780 |
| 60 | T cell selection (GO:0045058) | 3.13990361 |
| 61 | defense response to protozoan (GO:0042832) | 3.12693334 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.12142738 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.10124626 |
| 64 | detection of molecule of bacterial origin (GO:0032490) | 3.08745299 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 3.08643309 |
| 66 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04782689 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.04682778 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04375336 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.03841144 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02642724 |
| 71 | granulocyte activation (GO:0036230) | 3.02561880 |
| 72 | positive T cell selection (GO:0043368) | 3.02424346 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 3.02260890 |
| 74 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00974569 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00966599 |
| 76 | response to host (GO:0075136) | 3.00966599 |
| 77 | response to host defenses (GO:0052200) | 3.00966599 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 2.96710697 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94731604 |
| 80 | * detection of biotic stimulus (GO:0009595) | 2.93243903 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92840000 |
| 82 | * regulation of natural killer cell mediated immunity (GO:0002715) | 2.92787488 |
| 83 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92787488 |
| 84 | positive regulation of tolerance induction (GO:0002645) | 2.91366476 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90273898 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.88478694 |
| 87 | response to protozoan (GO:0001562) | 2.88062502 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86822623 |
| 89 | microglial cell activation (GO:0001774) | 2.86428972 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82938977 |
| 91 | macrophage activation (GO:0042116) | 2.82132334 |
| 92 | * negative regulation of innate immune response (GO:0045824) | 2.81152634 |
| 93 | T-helper 1 type immune response (GO:0042088) | 2.80339507 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 2.79234211 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78677774 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76450598 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 2.74265062 |
| 98 | negative regulation of type 2 immune response (GO:0002829) | 2.72999856 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.72786103 |
| 100 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.71942155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60559608 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16301511 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.66221100 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61560740 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43093636 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40030687 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15589489 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86080168 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77663474 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72040198 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69122203 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59776086 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50430148 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.44042217 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.43887264 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.43867266 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42150236 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39721478 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.39512836 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37577999 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31356103 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29445882 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.23477128 |
| 24 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21193413 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21049871 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20412648 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10640329 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.08201625 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07060912 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02648404 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01256975 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01160633 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00531936 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97627122 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.96292907 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94828894 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88589387 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84724695 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.83512014 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78054647 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76297968 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75096180 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71924532 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71337645 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69177583 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52639318 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52103269 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49984322 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46192051 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40337634 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40002961 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38554134 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37823872 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37643725 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37205766 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36802783 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33804372 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32735340 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32211322 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27284820 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26358883 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25049404 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24091496 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23614786 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19953137 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18296021 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16067303 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16043999 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15804380 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14174367 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13555359 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12479074 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11941241 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11932767 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10859202 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10711343 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09388165 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09169882 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08367257 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07373225 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06971028 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05710857 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04068355 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01227765 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00803057 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99428840 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98436102 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97859764 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97723530 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95821434 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95377314 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95355337 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95056823 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93638463 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93029034 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90150725 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89870771 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86496744 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85733701 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85639688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.03845737 |
| 2 | MP0003724_increased_susceptibility_to | 3.88778575 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.83414759 |
| 4 | MP0003303_peritoneal_inflammation | 3.56432819 |
| 5 | MP0005671_abnormal_response_to | 3.33380555 |
| 6 | MP0000685_abnormal_immune_system | 3.08882968 |
| 7 | MP0005387_immune_system_phenotype | 3.08408831 |
| 8 | MP0001790_abnormal_immune_system | 3.08408831 |
| 9 | MP0001800_abnormal_humoral_immune | 2.95184404 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.92741926 |
| 11 | MP0009785_altered_susceptibility_to | 2.89407347 |
| 12 | MP0005025_abnormal_response_to | 2.84935449 |
| 13 | MP0002419_abnormal_innate_immunity | 2.80560971 |
| 14 | MP0006082_CNS_inflammation | 2.72734085 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.70607307 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.67041197 |
| 17 | MP0002723_abnormal_immune_serum | 2.58066333 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.51742223 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.46276373 |
| 20 | MP0001819_abnormal_immune_cell | 2.43978031 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.43592986 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.22487703 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.09223005 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.07525685 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.05088738 |
| 26 | MP0002405_respiratory_system_inflammati | 1.97866708 |
| 27 | MP0004947_skin_inflammation | 1.94550208 |
| 28 | MP0000716_abnormal_immune_system | 1.87820116 |
| 29 | MP0002398_abnormal_bone_marrow | 1.87259459 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.87063142 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.84847212 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.80604929 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.73402835 |
| 34 | MP0003866_abnormal_defecation | 1.72421656 |
| 35 | MP0005451_abnormal_body_composition | 1.62604022 |
| 36 | MP0004510_myositis | 1.61126602 |
| 37 | MP0008260_abnormal_autophagy | 1.59641331 |
| 38 | MP0001873_stomach_inflammation | 1.57226535 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.53862689 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.53062507 |
| 41 | MP0008469_abnormal_protein_level | 1.52124684 |
| 42 | MP0002722_abnormal_immune_system | 1.51709389 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.50321278 |
| 44 | MP0002429_abnormal_blood_cell | 1.48647382 |
| 45 | MP0009840_abnormal_foam_cell | 1.46797278 |
| 46 | MP0005310_abnormal_salivary_gland | 1.45094090 |
| 47 | MP0000858_altered_metastatic_potential | 1.44541203 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.39298849 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.38819831 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.37320094 |
| 51 | MP0009278_abnormal_bone_marrow | 1.34036973 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.30179188 |
| 53 | MP0002132_abnormal_respiratory_system | 1.30166624 |
| 54 | MP0009764_decreased_sensitivity_to | 1.30046865 |
| 55 | MP0003075_altered_response_to | 1.27028869 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.24129071 |
| 57 | MP0001851_eye_inflammation | 1.19508770 |
| 58 | MP0005166_decreased_susceptibility_to | 1.18559759 |
| 59 | MP0000604_amyloidosis | 1.14878958 |
| 60 | MP0003828_pulmonary_edema | 1.13180116 |
| 61 | MP0001853_heart_inflammation | 1.12733322 |
| 62 | MP0004381_abnormal_hair_follicle | 1.11305808 |
| 63 | MP0002933_joint_inflammation | 1.11111770 |
| 64 | MP0000343_altered_response_to | 1.01472634 |
| 65 | MP0003448_altered_tumor_morphology | 1.00707012 |
| 66 | MP0000490_abnormal_crypts_of | 0.99103739 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 0.98825371 |
| 68 | MP0001663_abnormal_digestive_system | 0.98381108 |
| 69 | MP0004883_abnormal_blood_vessel | 0.97866482 |
| 70 | MP0003690_abnormal_glial_cell | 0.94315751 |
| 71 | MP0001545_abnormal_hematopoietic_system | 0.93019202 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.93019202 |
| 73 | MP0005164_abnormal_response_to | 0.92044714 |
| 74 | MP0002006_tumorigenesis | 0.91727865 |
| 75 | MP0005390_skeleton_phenotype | 0.88725073 |
| 76 | MP0009763_increased_sensitivity_to | 0.88558378 |
| 77 | MP0003091_abnormal_cell_migration | 0.84543859 |
| 78 | MP0003045_fibrosis | 0.84070637 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.82964935 |
| 80 | MP0002254_reproductive_system_inflammat | 0.77941807 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.77603530 |
| 82 | MP0003795_abnormal_bone_structure | 0.74058060 |
| 83 | MP0000249_abnormal_blood_vessel | 0.72989461 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 0.72521437 |
| 85 | MP0008004_abnormal_stomach_pH | 0.72398596 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.64838134 |
| 87 | MP0003329_amyloid_beta_deposits | 0.64773231 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.64607977 |
| 89 | MP0008874_decreased_physiological_sensi | 0.63774118 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.59928149 |
| 91 | MP0000609_abnormal_liver_physiology | 0.59829818 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.57532743 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.52425480 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.51344782 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.50792093 |
| 96 | MP0005023_abnormal_wound_healing | 0.50450441 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.50197944 |
| 98 | MP0005360_urolithiasis | 0.49364332 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.48873965 |
| 100 | MP0000920_abnormal_myelination | 0.48756002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.20407374 |
| 2 | Myositis (HP:0100614) | 5.08567500 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.97757265 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.96403418 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.90593679 |
| 6 | Orchitis (HP:0100796) | 4.75082694 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.43059143 |
| 8 | Optic neuritis (HP:0100653) | 4.40704972 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.40704972 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.07098824 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.98905136 |
| 12 | Stomatitis (HP:0010280) | 3.97793216 |
| 13 | Meningitis (HP:0001287) | 3.89551533 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.87930280 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.81491519 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.71288302 |
| 17 | Vasculitis (HP:0002633) | 3.61269827 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57854650 |
| 19 | Obstructive lung disease (HP:0006536) | 3.57854650 |
| 20 | Increased IgE level (HP:0003212) | 3.50102013 |
| 21 | Recurrent skin infections (HP:0001581) | 3.37830728 |
| 22 | Encephalitis (HP:0002383) | 3.31135919 |
| 23 | T lymphocytopenia (HP:0005403) | 3.28609482 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.27589972 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.19511825 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.16849971 |
| 27 | Abnormality of T cell number (HP:0011839) | 3.15795075 |
| 28 | Cellulitis (HP:0100658) | 3.15127207 |
| 29 | Gingivitis (HP:0000230) | 3.15037766 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14707580 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14707580 |
| 32 | Recurrent viral infections (HP:0004429) | 3.07521174 |
| 33 | Urticaria (HP:0001025) | 3.04591819 |
| 34 | Pustule (HP:0200039) | 2.92049764 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.90808359 |
| 36 | Chest pain (HP:0100749) | 2.89596434 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.87861473 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.87861473 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.87861473 |
| 40 | Increased IgM level (HP:0003496) | 2.86102959 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.85808339 |
| 42 | Gastrointestinal stroma tumor (HP:0100723) | 2.85666284 |
| 43 | Hemoptysis (HP:0002105) | 2.84961374 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.80588403 |
| 45 | Abnormality of T cells (HP:0002843) | 2.78024772 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.74036266 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.72033267 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.70825457 |
| 49 | Lymphopenia (HP:0001888) | 2.69989090 |
| 50 | Colitis (HP:0002583) | 2.68769640 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.62310942 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.60316001 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57839078 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.54343586 |
| 55 | Petechiae (HP:0000967) | 2.51250539 |
| 56 | Leukocytosis (HP:0001974) | 2.49697565 |
| 57 | Pulmonary embolism (HP:0002204) | 2.49177305 |
| 58 | Granulocytopenia (HP:0001913) | 2.48147212 |
| 59 | Nasal polyposis (HP:0100582) | 2.46885078 |
| 60 | Purpura (HP:0000979) | 2.46812274 |
| 61 | Loss of speech (HP:0002371) | 2.45223305 |
| 62 | Epistaxis (HP:0000421) | 2.44654980 |
| 63 | Arterial thrombosis (HP:0004420) | 2.41542626 |
| 64 | Osteomyelitis (HP:0002754) | 2.41085987 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.40502870 |
| 66 | Chronic otitis media (HP:0000389) | 2.40338007 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.39609171 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.38599350 |
| 69 | Chronic diarrhea (HP:0002028) | 2.35575310 |
| 70 | Gingival bleeding (HP:0000225) | 2.34431411 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.33684755 |
| 72 | Amyloidosis (HP:0011034) | 2.32555849 |
| 73 | Anorexia (HP:0002039) | 2.31663181 |
| 74 | IgM deficiency (HP:0002850) | 2.31005543 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.26436891 |
| 76 | Malnutrition (HP:0004395) | 2.26033415 |
| 77 | Episodic fever (HP:0001954) | 2.25683833 |
| 78 | Restrictive lung disease (HP:0002091) | 2.24589247 |
| 79 | Emphysema (HP:0002097) | 2.23422844 |
| 80 | Hypochromic anemia (HP:0001931) | 2.23388091 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.23068075 |
| 82 | Autoimmune hemolytic anemia (HP:0001890) | 2.22205163 |
| 83 | Gangrene (HP:0100758) | 2.22057983 |
| 84 | Sepsis (HP:0100806) | 2.21841615 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.15017025 |
| 86 | Glomerulopathy (HP:0100820) | 2.08555659 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.08471577 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 2.07610870 |
| 89 | Hepatosplenomegaly (HP:0001433) | 2.07441033 |
| 90 | Skin ulcer (HP:0200042) | 2.07322051 |
| 91 | Eosinophilia (HP:0001880) | 2.06881331 |
| 92 | Increased serum ferritin (HP:0003281) | 2.02363343 |
| 93 | Arthralgia (HP:0002829) | 2.01992760 |
| 94 | Vacuolated lymphocytes (HP:0001922) | 2.01315933 |
| 95 | Recurrent pneumonia (HP:0006532) | 2.01150641 |
| 96 | Joint swelling (HP:0001386) | 2.00250532 |
| 97 | Peritonitis (HP:0002586) | 1.99462217 |
| 98 | Verrucae (HP:0200043) | 1.96096305 |
| 99 | Papilloma (HP:0012740) | 1.96096305 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94533735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.26369273 |
| 2 | RIPK4 | 3.96787775 |
| 3 | ERN1 | 3.51249683 |
| 4 | TYK2 | 3.01204537 |
| 5 | PRPF4B | 2.92817820 |
| 6 | BLK | 2.56311901 |
| 7 | IRAK4 | 2.53821579 |
| 8 | CSK | 2.38753495 |
| 9 | MAP2K3 | 2.25946670 |
| 10 | MAP3K14 | 2.15384129 |
| 11 | ZAP70 | 2.09886922 |
| 12 | TXK | 2.09425343 |
| 13 | FES | 2.03953748 |
| 14 | EPHB1 | 1.98225113 |
| 15 | TBK1 | 1.95831033 |
| 16 | JAK3 | 1.93955840 |
| 17 | IKBKE | 1.86852504 |
| 18 | MAP3K13 | 1.83788225 |
| 19 | GRK6 | 1.83113005 |
| 20 | MAP3K3 | 1.77271775 |
| 21 | BTK | 1.75666247 |
| 22 | TNK2 | 1.75658960 |
| 23 | JAK1 | 1.70928989 |
| 24 | MAP3K11 | 1.60561017 |
| 25 | SYK | 1.57878324 |
| 26 | TAOK1 | 1.53084716 |
| 27 | FGFR4 | 1.52083665 |
| 28 | HCK | 1.48911460 |
| 29 | SMG1 | 1.42385083 |
| 30 | TRIB3 | 1.41628700 |
| 31 | SIK3 | 1.41610328 |
| 32 | FGR | 1.35955722 |
| 33 | TESK2 | 1.29406780 |
| 34 | LYN | 1.27218477 |
| 35 | LCK | 1.25494957 |
| 36 | ITK | 1.22830794 |
| 37 | CSF1R | 1.22311974 |
| 38 | KIT | 1.21643130 |
| 39 | MAP3K1 | 1.21242266 |
| 40 | TAOK2 | 1.20709836 |
| 41 | JAK2 | 1.18287066 |
| 42 | IKBKB | 1.16655723 |
| 43 | TAOK3 | 1.04608968 |
| 44 | SIK1 | 0.96745160 |
| 45 | STK10 | 0.96623695 |
| 46 | MARK3 | 0.96339415 |
| 47 | IRAK3 | 0.94522042 |
| 48 | FGFR3 | 0.94267912 |
| 49 | PTK6 | 0.94192791 |
| 50 | SIK2 | 0.93694273 |
| 51 | CDC42BPA | 0.93668873 |
| 52 | MATK | 0.88977446 |
| 53 | RIPK1 | 0.86311767 |
| 54 | PRKD2 | 0.83986859 |
| 55 | TGFBR2 | 0.83065181 |
| 56 | PDK1 | 0.82759058 |
| 57 | HIPK2 | 0.81316219 |
| 58 | KSR2 | 0.77708314 |
| 59 | MARK2 | 0.77492416 |
| 60 | EPHA3 | 0.74361986 |
| 61 | PDPK1 | 0.72094293 |
| 62 | IRAK1 | 0.71546504 |
| 63 | TEC | 0.70806604 |
| 64 | BMPR2 | 0.69834270 |
| 65 | YES1 | 0.68851578 |
| 66 | LRRK2 | 0.64549898 |
| 67 | PRKCQ | 0.63439319 |
| 68 | MAPK7 | 0.62184973 |
| 69 | FYN | 0.60933530 |
| 70 | MAPK12 | 0.59490609 |
| 71 | MAP3K7 | 0.56580941 |
| 72 | NLK | 0.55763363 |
| 73 | GRK7 | 0.54727263 |
| 74 | MAPK11 | 0.54501257 |
| 75 | CAMKK1 | 0.47951282 |
| 76 | IRAK2 | 0.47284571 |
| 77 | MAP2K6 | 0.47205370 |
| 78 | PIM1 | 0.47034267 |
| 79 | CHUK | 0.43642517 |
| 80 | KDR | 0.43183093 |
| 81 | MAP3K10 | 0.42983345 |
| 82 | MAPKAPK2 | 0.42337431 |
| 83 | MAP3K6 | 0.41607928 |
| 84 | TESK1 | 0.41402162 |
| 85 | RPS6KL1 | 0.39640319 |
| 86 | RPS6KC1 | 0.39640319 |
| 87 | DYRK1B | 0.38789820 |
| 88 | RET | 0.37262048 |
| 89 | MAP3K5 | 0.37150233 |
| 90 | CDK4 | 0.37003755 |
| 91 | PRKG2 | 0.34931814 |
| 92 | CAMKK2 | 0.34383366 |
| 93 | MOS | 0.34124851 |
| 94 | MAP3K2 | 0.33993260 |
| 95 | MAP3K8 | 0.32831801 |
| 96 | ICK | 0.32642887 |
| 97 | BMX | 0.31610541 |
| 98 | CDK19 | 0.29094879 |
| 99 | RPS6KA6 | 0.28952273 |
| 100 | PTK2B | 0.28716495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Allograft rejection_Homo sapiens_hsa05330 | 3.10892369 |
| 2 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95896375 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.90221754 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80924267 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79403695 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.72770835 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63539728 |
| 8 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27203731 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.25090643 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19644995 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15731404 |
| 12 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12248500 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.06275267 |
| 14 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.02159296 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96427887 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94500327 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91825493 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.90585975 |
| 19 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.90315563 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.80580148 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70588740 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70171727 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67299439 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66221866 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.60571206 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54395298 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.54084588 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53829215 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52850337 |
| 30 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.51868819 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45308999 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43132426 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37693215 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32860953 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29769630 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27522121 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26145040 |
| 38 | * Phagosome_Homo sapiens_hsa04145 | 1.22607595 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.19272494 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.17020718 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.14034777 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11636901 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09249066 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.09126702 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.07216965 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.00554813 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00416294 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.96013050 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94622845 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.93207404 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90964801 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90474779 |
| 53 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86661581 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84488313 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83475995 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82280574 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.81365996 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80017434 |
| 59 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75797850 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73783606 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71970599 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71757172 |
| 63 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68463974 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65654398 |
| 65 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.63959702 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62709434 |
| 67 | * Endocytosis_Homo sapiens_hsa04144 | 0.62655948 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61461238 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60383643 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58279644 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56384113 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49963231 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.49625525 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48834206 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.47196597 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45563407 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45392675 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41499764 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40552571 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40514676 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39794493 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39590755 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39059220 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37069790 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36083617 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35528529 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33862320 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.33571964 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32410557 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31533651 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30356093 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.28922365 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28603737 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28392525 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27809263 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27640972 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27598549 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24287691 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22583518 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22296671 |

